Pharmacokinetic and other considerations for drug therapy during targeted temperature management

Critical Care Medicine

Volumn 43, Issue 10, 2015, Pages 2228-2238

  Šunjić, Katlynd M ^a   Webb, Adam C ^b   Šunjić, Igor ^c   Creus, Monica Pala ^d   Folse, Stacey L ^e,f  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF NAVARRA   (Spain)

^e EMORY UNIVERSITY HOSPITAL   (United States)

^f MERCER UNIVERSITY   (United States)

Author keywords

Cardiac arrest; Drug interaction; Neuroprotection; Pharmacodynamics; Pharmacokinetics; Targeted temperature management; Therapeutic hypothermia

Indexed keywords

ANESTHETIC AGENT; ELECTROLYTE; NEUROMUSCULAR BLOCKING AGENT; OPIATE;

ANALGESIA; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING DISORDER; CEREBROVASCULAR ACCIDENT; CORE TEMPERATURE; DATA BASE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEART SURGERY; HEMODYNAMIC MONITORING; HUMAN; HYPOTHERMIA; INDUCED HYPOTHERMIA; MEDLINE; NEUROPROTECTION; PARALYSIS; PATHOPHYSIOLOGY; PHARMACODYNAMIC PARAMETERS; PHARMACOKINETIC PARAMETERS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEDATION; SEIZURE; SHIVERING; THERMOREGULATION; ADVERSE EFFECTS; PHARMACOKINETICS;

HEART ARREST; HUMANS; HYPOTHERMIA, INDUCED; PHARMACOKINETICS; SHIVERING;

EID: 84941902944     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001223     Document Type: Review

References (113)

1. Benson DW, Williams GR Jr, Spencer FC, et al: The use of hypothermia after cardiac arrest. Anesth Analg 1959;38:423-428
2. Safar P: Community-wide cardiopulmonary resuscitation. J Iowa Med Soc 1964;54:629-635
3. The Hypothermia After Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurological outcome after cardiac arrest. N Engl J Med 2002;346:549-556
4. Bernard SA, Gray TW, Buist MD, et al: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-563
5. Nielsen N, Wetterslev J, Cronberg T, et al; TTM Trial Investigators: Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med 2013;369:2197-2206
6. Tortorici MA, Kochanek PM, Poloyac SM: Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermiamediated alterations on the cytochrome P450 enzyme system. Crit Care Med 2007;35:2196-2204
7. e. Bethesda, MD, American Society of Health-System Pharmacists, Inc, 2010. pp 1-49
8. e. Shargel L, Wu-Pong S, Yu AC (Eds). New York, NY, McGraw-Hill; 2012
9. Udassin R, Vromen A, Haskel Y: The time sequence of injury and recovery following transient reversible intestinal ischemia. J Surg Res 1994;56:221-225
10. Hebra A, Brown MF, McGeehin K, et al: The effects of ischemia and reperfusion on intestinal motility. J Pediatr Surg 1993;28:362-365
11. Hassoun HT, Weisbrodt NW, Mercer DW, et al: Inducible nitric oxide synthase mediates gut ischemia/reperfusion-induced ileus only after severe insults. J Surg Res 2001;97:150-154
12. Attuwaybi BO, Hassoun HT, Zou L, et al: Hypothermia protects against gut ischemia/reperfusion-induced impaired intestinal transit by inducing heme oxygenase-1. J Surg Res 2003;115:48-55
13. Lazenby WD, Ko W, Zelano JA, et al: Effects of temperature and flow rate on regional blood flow and metabolism during cardiopulmonary bypass. Ann Thorac Surg 1992;53:957-964
14. Kondratiev TV, Myhre ES, Simonsen O, et al: Cardiovascular effects of epinephrine during rewarming from hypothermia in an intact animal model. J Appl Physiol (1985) 2006;100:457-464
15. Chen RY, Chien S: Plasma volume, red cell volume, and thoracic duct lymph flow in hypothermia. Am J Physiol 1977;233:H605-H612
16. Chen RY, Chien S: Hemodynamic functions and blood viscosity in surface hypothermia. Am J Physiol 1978;235:H136-H143
17. Dámato HE, Hegnauer AH. Blood volume in the hypothermic dog. Am J Physiol 1953;173:100-102.
18. Lofstrom B: Changes in blood volume in induced hypothermia. Acta Anaesthesiol Scand 1957;1:1-13
19. Koren G, Barker C, Bohn D, et al: Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets. Crit Care Med 1985;13:844-847
20. Wong KC: Physiology and pharmacology of hypothermia. West J Med 1983;138:227-232
21. Shepherd AMM, Emslie-Smith D, Stevenson IH. Antipyrine elimination in patients with hypothermia. Br J Clin Pharmacol 1976;3:958-959P
22. Iida Y, Nishi S, Asada A: Effect of mild therapeutic hypothermia on phenytoin pharmacokinetics. Ther Drug Monit 2001;23:192-197
23. Heier T, Clough D, Wright PM, et al: The influence of mild hypothermia on the pharmacokinetics and time course of action of neostigmine in anesthetized volunteers. Anesthesiology 2002;97:90-95
24. Fukuoka N, Aibiki M, Tsukamoto T, et al: Biphasic concentration change during continuous midazolam administration in brain-injured patients undergoing therapeutic moderate hypothermia. Resuscitation 2004;60:225-230
25. Jin JS, Sakaeda T, Kakumoto M, et al: Effect of therapeutic moderate hypothermia on multi-drug resistance protein 1-mediated transepithelial transport of drugs. Neurol Med Chir (Tokyo) 2006;46:321-327
26. Delin NA, Kjartansson KB, Pollock L, et al: Redistribution of regional blood flow in hypothermia. J Thorac Cardiovasc Surg 1965;49:511-516
27. Arpino PA, Greer DM: Practical pharmacologic aspects of therapeutic hypothermia after cardiac arrest. Pharmacotherapy 2008;28:102-111
28. Zhou J, Poloyac SM: The effect of therapeutic hypothermia on drug metabolism and response: Cellular mechanisms to organ function. Expert Opin Drug Metab Toxicol 2011;7:803-816
29. Pang KS, Rowland M: Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm 1977;5:625-653
30. Daemen MJ, Thijssen HH, Vervoort-Peters HT, et al: The effect of pentobarbitone anaesthesia and hypothermia on the hepatic clearance of indocyanine green and S (-)-acenocoumarol in the rat. J Pharm Pharmacol 1986;38:122-125
31. MacLaren R, Gallagher J, Shin J, et al: Assessment of adverse events and predictors of neurological recovery after therapeutic hypothermia. Ann Pharmacother 2014;48:17-25
32. De Witte J, Sessler DI: Perioperative shivering: Physiology and pharmacology. Anesthesiology 2002;96:467-484
33. Hales JRS. Skin arteriovenous anastomoses, their control and role in thermoregulation. In: Cardiovascular Shunts: Phylogenetic, ontogenetic, and clinical aspects. Johansen K, Burggren W (Eds). Copenhagen, Denmark, Munksgaard, 1985, pp 433-451
34. Sessler DI: Thermoregulatory defense mechanisms. Crit Care Med 2009;37:S203-S210
35. Sessler DI: Defeating normal thermoregulatory defenses: Induction of therapeutic hypothermia. Stroke 2009;40:e614-e621
36. Nair SU, Lundbye JB: The occurrence of shivering in cardiac arrest survivors undergoing therapeutic hypothermia is associated with a good neurologic outcome. Resuscitation 2013;84:626-629
37. Badjatia N: Hyperthermia and fever control in brain injury. Crit Care Med 2009;37:S250-S257
38. Lopez M, Sessler DI, Walter K, et al: Rate and gender dependence of the sweating, vasoconstriction, and shivering thresholds in humans. Anesthesiology 1994;80:780-788
39. Mokhtarani M, Mahgoub AN, Morioka N, et al: Buspirone and meperidine synergistically reduce the shivering threshold. Anesth Analg 2001;93:1233-1239
40. Lenhardt R, Orhan-Sungur M, Komatsu R, et al: Suppression of shivering during hypothermia using a novel drug combination in healthy volunteers. Anesthesiology 2009;111:110-115
41. Matsukawa T, Kurz A, Sessler DI, et al: Propofol linearly reduces the vasoconstriction and shivering thresholds. Anesthesiology 1995;82:1169-1180
42. Leslie K, Sessler DI, Bjorksten AR, et al: Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium. Anesth Analg 1995;80:1007-1014
43. Choi HA, Ko SB, Presciutti M, et al: Prevention of shivering during therapeutic temperature modulation: The Columbia anti-shivering protocol. Neurocrit Care 2011;14:389-394
44. Dexmedetomidine [prescribing information]. Lake Forest, IL, Hospira, Inc, March 2013
45. Sato K, Kimura T, Nishikawa T, et al: Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats. Acta Anaesthesiol Scand 2010;54:377-382
46. Kasner SE, Wein T, Piriyawat P, et al: Acetaminophen for altering body temperature in acute stroke: A randomized clinical trial. Stroke 2002;33:130-134
47. Dippel DW, Van Breda EJ, Van Gemert HM, et al: Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: A double-blind, randomized phase II clinical trial. Stroke 2001;32:1607-1612
48. Dippel DW, Van Breda EJ, Van Der Worp HB, et al; PISA-Investigators: Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial [ISRCTN98608690]. BMC Cardiovasc Disord 2003;3:2
49. Den Hertog HM, Van Der Worp HB, Van Gemert HM, et al; PAIS Investigators: The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: A multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol 2009;8:434-440
50. Buspirone [prescribing information]. Princeton, NJ, Bristol-Myers Squibb Company, December 2010
51. Young AH, McShane R, Park SB, et al: Buspirone-induced hypothermia in normal male volunteers. Biol Psychiatry 1993;34:665-666
52. Morrison EK, Rowe AS: Probable drug-drug interaction leading to serotonin syndrome in a patient treated with concomitant buspirone and linezolid in the setting of therapeutic hypothermia. J Clin Pharm Ther 2012;37:610-613
53. Midazolam [prescribing information]. Lake Forest, IL, Akorn, Inc, August 2012
54. Hostler D, Zhou J, Tortorici MA, et al: Mild hypothermia alters midazolam pharmacokinetics in normal healthy volunteers. Drug Metab Dispos 2010;38:781-788
55. Jacobi J, Fraser GL, Coursin DB, et al; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-141
56. Beaufort AM, Wierda JM, Belopavlovic M, et al: The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans. Eur J Anaesthesiol Suppl 1995;11:95-106
57. Mueller SW, Winn R, Macht M, et al: Neuromuscular blockade resistance during therapeutic hypothermia. Ann Pharmacother 2011;45:e15
58. Murray MJ, Cowen J, De Block H, et al; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists, American College of Chest Physicians: Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002;30:142-156
59. Warr J, Thiboutot Z, Rose L, et al: Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Ann Pharmacother 2011;45:1116-1126
60. Lascarrou JB, Le Gouge A, Dimet J, et al: Neuromuscular blockade during therapeutic hypothermia after cardiac arrest: Observational study of neurological and infectious outcomes. Resuscitation 2014;85:1257-1262
61. Salciccioli JD, Cocchi MN, Rittenberger JC, et al: Continuous neuromuscular blockade is associated with decreased mortality in postcardiac arrest patients. Resuscitation 2013;84:1728-1733
62. Buist M, Easther R: Mill's canons, neuro-muscular blockade (NMB), therapeutic hypothermia (TH), and outcomes from out of hospital cardiac arrest (OHCA). Resuscitation 2013;84:1648-1649
63. Fritz HG, Holzmayr M, Walter B, et al: The effect of mild hypothermia on plasma fentanyl concentration and biotransformation in juvenile pigs. Anesth Analg 2005;100:996-1002
64. Tempelhoff R, Modica PA, Bernardo KL, et al: Fentanyl-induced electrocorticographic seizures in patients with complex partial epilepsy. J Neurosurg 1992;77:201-208
65. Statler KD, Alexander HL, Vagni VA, et al: Moderate hypothermia may be detrimental after traumatic brain injury in fentanyl-anesthetized rats. Crit Care Med 2003;31:1134-1139
66. Bjelland TW, Klepstad P, Haugen BO, et al: Concentrations of remifentanil, propofol, fentanyl, and midazolam during rewarming from therapeutic hypothermia. Acta Anaesthesiol Scand 2014;58:709-715
67. Barr J, Fraser GL, Puntillo K, et al; American College of Critical Care Medicine: Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41:263-306
68. Geocadin RG, Eleff SM: Cardiac arrest resuscitation: Neurologic prognostication and brain death. Curr Opin Crit Care 2008;14:261-268
69. Webb AC, Samuels OB: Reversible brain death after cardiopulmonary arrest and induced hypothermia. Crit Care Med 2011;39:1538-1542
70. Zydlewski AW, Hasbargen JA: Hypothermia-induced hypokalemia. Mil Med 1998;163:719-721
71. Phillipson EA, Herbert FA: Accidental exposure to freezing: Clinical and laboratory observations during convalescence from near-fatal hypothermia. Can Med Assoc J 1967;97:786-792
72. Bruining HA, Boelhouwer RU: Acute transient hypokalemia and body temperature. Lancet 1982;2:1283-1284
73. Munday KA, Blane GF, Chin EF, et al: Plasma electrolyte changes in hypothermia. Thorax 1958;13:334-342
74. Todd EP, Campbell HC, Utley JR, et al: Effect of beta-adrenergic blockade on hypothermia-induced hypokalemia. Surg Forum 1977;28:275-276
75. Sprung J, Gamulin S, Bosnjak ZJ, et al: Potassium correction of hypothermic hypokalemia induces hyperkalemia after rewarming. Can J Anaesth 1990;37:S69
76. Kanter GS: Regulation of extracellular potassium in hypothermia. Am J Physiol 1963;205:1285-1289
77. Shida H, et al. Changes of serum electrolyte at open heart surgery with simple profound hypothermia: Relation between transient hypopotassemia and metabolic acidosis. Jpn J Thorac Surg 1973;26:723-726
78. Machida S, et al. Experimental study on tissue distribution of potassium during simple hypothermia. Jpn J Thorac Surg 1977;30:413-418
79. Mirzoyev SA, McLeod CJ, Bunch TJ, et al: Hypokalemia during the cooling phase of therapeutic hypothermia and its impact on arrhythmogenesis. Resuscitation 2010;81:1632-1636
80. Polderman KH, Peerdeman SM, Girbes AR: Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. J Neurosurg 2001;94:697-705
81. Kraft MD, Btaiche IF, Sacks GS, et al: Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm 2005;62:1663-1682
82. Polderman KH: Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009;37:S186-S202
83. Bro-Jeppesen J, Hassager C, Wanscher M, et al: Targeted temperature management at 33°C versus 36°C and impact on systemic vascular resistance and myocardial function after out-of-hospital cardiac arrest: A sub-study of the Target Temperature Management Trial. Circ Cardiovasc Interv 2014;7:663-672
84. Polderman KH, Herold I: Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods. Crit Care Med 2009;37:1101-1120
85. Scirica BM: Therapeutic hypothermia after cardiac arrest. Circulation 2013;127:244-250
86. Delhaye C, Mahmoudi M, Waksman R. The effects of hypothermia on human left ventricular contractile function during cardiac surgery. J Am Coll Cardiol 2012;197:197-210
87. Aslam AF, Aslam AK, Vasavada BC, et al: Hypothermia: Evaluation, electrocardiographic manifestations, and management. Am J Med 2006;119:297-301
88. Mattu A, Brady WJ, Perron AD: Electrocardiographic manifestations of hypothermia. Am J Emerg Med 2002;20:314-326
89. Polderman KH, Varon J: When better is the enemy of good: The optimal heart rate during therapeutic cooling. Crit Care Med 2014;42:2452-2454
90. Stær-Jensen H, Sunde K, Olasveengen TM, et al: Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survivors of out-of-hospital cardiac arrest. Crit Care Med 2014;42:2401-2408
91. Tveita, Sieck GC. Effects of milrinone of left ventricular cardiac function during cooling in an intact animal model. Cryobiology 2012;65:27-32.
92. Filseth OM, How OJ, Kondratiev T, et al: Changes in cardiovascular effects of dopamine in response to graded hypothermia in vivo. Crit Care Med 2012;40:178-186
93. Lebiedz P, Meiners J, Samol A, et al: Electrocardiographic changes during therapeutic hypothermia. Resuscitation 2012;83:602-606
94. Piktel JS, Rosenbaum DS, Wilson LD: Mild hypothermia decreases arrhythmia susceptibility in a canine model of global myocardial ischemia. Crit Care Med 2012;40:2954-2959
95. Khan JN, Prasad N, Glancy JM: QTc prolongation during therapeutic hypothermia: Are we giving it the attention it deserves? Europace 2010;12:266-270
96. Storm C, Hasper D, Nee J, et al: Severe QTc prolongation under mild hypothermia treatment and incidence of arrhythmias after cardiac arrest-a prospective study in 34 survivors with continuous Holter ECG. Resuscitation 2011;82:859-862
97. Lam DH, Dhingra R, Conley SM, et al: Therapeutic hypothermiainduced electrocardiographic changes and relations to in-hospital mortality. Clin Cardiol 2014;37:97-102
98. Nishiyama N, Sato T, Aizawa Y, et al. Extreme QT prolongation during therapeutic hypothermia after cardiac arrest due to long QT syndrome: A case report. Am J Emerg Med 2012;638. e5-638.e8.
99. Dietrichs ES, Kondratiev T, Tveita T: Milrinone ameliorates cardiac mechanical dysfunction after hypothermia in an intact rat model. Cryobiology 2014;69:361-366
100. Schmied H, Kurz A, Sessler DI, et al: Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996;347:289-292
101. Ivan C Jr, Vladimir S, Martin P, Pavel S, Iveta R, Vaclav Z. The influence of temperature adjustment on thromboelastogaphy results: prospective cohort study. Anesteziol Intenzivni Med 2011;22:253-259.
102. Spiel AO, Kliegel A, Janata A, et al: Hemostasis in cardiac arrest patients treated with mild hypothermia initiated by cold fluids. Resuscitation 2009;80:762-765
103. Peberdy MA, Callaway CW, Neumar RW, et al; American Heart Association: Part 9: Post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010;122:S768-S786
104. Spahn DR, Cerny V, Coats TJ. Management of bleeding following major trauma: A European guideline. Critical Care 2007, 11:R17
105. Michelson AD, MacGregor H, Barnard MR, et al: Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 1994;71:633-640
106. Rohrer MJ, Natale AM: Effect of hypothermia on the coagulation cascade. Crit Care Med 1992;20:1402-1405
107. Watts DD, Trask A, Soeken K, et al: Hypothermic coagulopathy in trauma: Effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998;44:846-854
108. Valeri CR, Feingold H, Cassidy G, et al: Hypothermia-induced reversible platelet dysfunction. Ann Surg 1987;205:175-181
109. Michelson AD, Barnard MR, Khuri SF, et al: The effects of aspirin and hypothermia on platelet function in vivo. Br J Haematol 1999;104:64-68
110. Bjelland TW, Hjertner Ø, Klepstad P, et al: Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Resuscitation 2010;81:1627-1631
111. Ford NF: Clopidogrel resistance: Pharmacokinetic or pharmacogenetic? J Clin Pharmacol 2009;49:506-512
112. Kander T, Dankiewicz J, Friberg H, et al: Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study. Crit Care 2014;18:495
113. Frelinger AL III, Furman MI, Barnard MR, et al: Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on plateletplatelet and leukocyte-platelet aggregation. Am J Cardiol 2003;92:1099-1101